The Effect of Pravastatin, Bezafibrate and Cholexamine in a Non-Obese Boundary-Type Diabetic With the Hyperlipidemia on Glucose tolerance.The Change of Blood Sugar at 75gOGTT, Insulin, C-Peptide/Insulin Ratio, Free Fatty Acid.
Japanese Journal of Clinical Pharmacology and Therapeutics - Japan
doi 10.3999/jscpt.25.75
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 1994
Authors
Publisher
Japanese Society of Clinical Pharmacology and Therapeutics